Gastrointestinal Perforation After Treatment With Tocilizumab : An Unexpected Consequence of COVID-19 Pandemic

Am Surg. 2020 Jun;86(6):565-566. doi: 10.1177/0003134820926481.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Betacoronavirus
  • COVID-19
  • COVID-19 Drug Treatment
  • Colonic Diseases / chemically induced*
  • Colonic Diseases / diagnostic imaging
  • Colonic Diseases / surgery
  • Coronavirus Infections / drug therapy*
  • Coronavirus Infections / epidemiology
  • Drug Therapy, Combination
  • Fatal Outcome
  • Female
  • Hematoma / chemically induced
  • Hematoma / diagnostic imaging
  • Hematoma / surgery
  • Humans
  • Intestinal Perforation / chemically induced*
  • Intestinal Perforation / diagnostic imaging
  • Intestinal Perforation / surgery
  • Methylprednisolone / therapeutic use
  • Middle Aged
  • Pandemics
  • Pneumonia, Viral / drug therapy*
  • Pneumonia, Viral / epidemiology
  • SARS-CoV-2
  • Tomography, X-Ray Computed

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal, Humanized
  • tocilizumab
  • Methylprednisolone